Deborah Adams Kaplan

Collections of oncology drugs in 13 states are being redistributed to patients in need.

Drug manufacturers are rejecting the program’s blanket discounts involving contract pharmacies. A flurry of litigation has ensued.

The Big Three all set up group purchasing organizations recently, but some industry observers question the timing of the move and who will benefit.

A Kaiser Family Foundation survey found that all the responding programs had at least one initiative to expand behavioral health services.